Nobio

Developer of bio-protection technology designed to produce antimicrobial materials, products, and surfaces.

Industrial Technologies
Active
Mature Kadima Zoran, Israel Founded 2015
Last updated 2026-07-20
Total raised
$4.0M
Last: Undisclosed Round 2021-01
Stage
Mature
Founded
2015
Headcount
28
HQ
Kadima Zoran, Israel
Sector
Industrial Technologies

About

Nobio is an advanced material science company that has developed a breakthrough technology utilizing proprietary, non-soluble quaternary-ammonium silica (QASi™) molecules to create long-lasting, safe, and highly active antimicrobial products and solutions. The company's technology transforms various materials, products, and surfaces into antimicrobial agents, providing strong, safe, and durable bio-protection. Nobio is currently focused on dental applications with its Infinix™ line of antibacterial dental materials, which have received FDA clearance. The technology also has potential applications in medical devices, food packaging, and other consumer and industrial products.

Funding history · 4 rounds · $4.0M total

2020-12
B Round Undisclosed
2020-03
Grant $205K
2018-07
A Round $3.6M
★ aMoon Fund★ Dr. Ole Jensen
2016-10
Grant $200K

Headcount over time

From 9 (2018-08) to 27 (2025-12) · +18 (+200%) · 40 points · source: Finder history + radar grounding
370 2018-08 2025-12

Q&A

What is Nobio's primary focus?
Nobio develops long-term antibacterial and antiviral solutions for medical, dental, and consumer products, commercializing its technology through its own products and industry partnerships.
When was Nobio founded?
Nobio was founded in July 2015.
What significant regulatory approval did Nobio receive in 2019?
In September 2019, Nobio received FDA approval to market Infinix, its line of antibacterial products for dental fillings.
What is Nobio's total funding raised to date?
Nobio has raised a total of $4,005,000 USD.
Which investors participated in Nobio's August 2018 funding round?
In August 2018, Nobio received funding from Dr. Ole Jensen and aMoon Fund.
What is the core technology behind Nobio's solutions?
Nobio's core technology involves potent particles covered with highly active antimicrobial molecules that kill a wide range of microorganisms on contact. These particles can be permanently embedded in or used as a coating on various products and materials.
How did Nobio respond to the COVID-19 pandemic?
In response to COVID-19, Nobio began implementing its technology in personal protective equipment (PPE) and surface coatings, and received a grant from the Israeli Innovation Authority for its work on PPE in April 2020.

Team · 2

Prof. Ervin Weiss
Founder · Co-founder
Julia Rothman
Founder · Co-founder

Sectors & technology

Primary sector
Industrial Technologies
Sub-sectors
Industrial TechnologiesMaterial Innovations & Applications
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesHealthcareProvidersLaboratoriesIndustrial ManufacturingManufacturing Facilities
Business model
B2BB2B2C

Highlights

1 Patents

Tags

bioconvergencedentistspharmaceuticalsnanotechnologymedical-devicesdentalbiotechnologymaterialsmedical-equipmentmicrobiologypackaging-and-containerstextilemanufacturing-facilitieshygienesurface-and-coatingshvachospitals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitenobio.com
LinkedInlinkedin.com/company/28606342
YouTubeyoutube.com/channel/UCLCSA_6Cf8KV5NLSSFrSg4A

Identifiers & details

Legal nameNobio Ltd.
Former namesNanoLock
Founded2015
Employees (exact)28

Radar intelligence

Patents

EPO6

Publications (Crossref)

Works1

Web history (Wayback)

Domainnobio.com

Certificate / subdomain footprint

Subdomains8

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515281285
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2015-07-01
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2025
Active charges / liens0
Registry events4 — shares_capital (4)
Registered addressהמתכת 8 קדימה

Recent registry events

DateEvent
2026-05-18שינוי בהרכב הון - מניות-שינוי סוג מניה
2026-06-03הקצאת מניות
2026-06-03שינוי בהרכב הון - מניות-הפחתת הון מוקצה
2026-06-03העברת מניות